The most consequential news out of First Phosphate this week had nothing to do with the annual shareholder meeting that took place on August 28 — even though that gathering produced approval ratings north of 96 percent for every director on the slate. The real signal came from Ottawa, where the Canadian export credit agency EIFO has now formally dangled a guarantee of up to 275 million Canadian dollars behind the company’s Begin-Lamarche mine project.
That commitment has already moved the needle in the models that matter. Emerging Growth Research, in a flash report published Wednesday, trimmed its discount rate for the proposed mine from 11.5 percent to 10.5 percent, and for the associated phosphoric acid plant from 13.5 percent to 12.5 percent. The 100-basis-point reductions on each side of the ledger reflect a straightforward piece of valuation logic: a government-backed guarantee lowers the perceived default risk of a project, which in turn lifts the present value of its future cash flows.
A shareholder base that grew 861 percent in a year
The annual meeting itself delivered what looks at first glance like boilerplate results. All five director candidates were confirmed with support ranging from 96.73 percent to 99.53 percent. Davidson & Company LLP was retained as auditor, an advance notice policy was adopted, and a revised stock option plan cleared the threshold — each with majorities above 96 percent.
But buried in the administrative detail is a number that tells a more interesting story. The company’s roster of registered and beneficial shareholders has swelled to 12,501, a jump of 861 percent from the 1,301 holders recorded a year earlier. That kind of expansion does not happen by accident. It reflects a structural shift in ownership — away from a tight circle of early backers and toward a broad, increasingly international base of investors drawn to the narrative of North American battery-grade phosphate production.
That narrative has geopolitical heft. With LFP battery cells becoming central to the electrification of supply chains, a company that can deliver battery-quality phosphoric acid without depending on Chinese processing capacity positions itself in a market actively hunting for alternatives. The stock market has been listening.
The market has run ahead of the fundamentals
The share price performance this year suggests investors have not just absorbed that story — they have front-run it. First Phosphate shares are up 101 percent since the start of the year, with roughly half of that gain concentrated in the past 30 days. In Frankfurt trading, the stock touched 1.45 euros on Wednesday, up 2.3 percent from Tuesday’s close of 1.42 euros, while the U.S.-listed shares added 1.16 percent to reach $16.50.
Should investors sell immediately? Or is it worth buying First Phosphate?
Yet the stock remains roughly 16 to 18 percent below its 52-week high of 1.73 euros, a level reached only about a week ago. The recent pullback — a 4.2 percent drop on Tuesday and a 13 percent slide over the course of the week — looks less like a warning shot than a pause for breath after an exceptionally steep climb. The volatility is part of the package: the annualized 30-day swing sits at 89 percent, a figure that investors in early-stage project developers have to accept as the cost of admission.
The catalyst calendar has been dense. A regulatory status change roughly three weeks ago delivered an initial gain of 26.2 percent, followed by a further 14.9 percent bump from the Nasdaq upgrade of the company’s ADRs. But an analyst commentary on the feasibility study published about a week ago weighed on the shares, which have traded 6.0 percent lower since.
What comes next hinges on a study due in 2027
Emerging Growth Research points to the upcoming feasibility study for Begin-Lamarche, expected early in 2027, as the next genuine milestone. That document should deliver harder numbers on capital costs, production capacity, and overall economics than the preliminary assessments currently on the table. Until then, much of the adjusted modeling remains provisional — including the newly lowered discount rates.
The broader phosphate sector is meanwhile stirring. In the United States, CHS and OCP North America are advancing a joint fertilizer plant in Louisiana with an investment of up to $450 million — the first facility of its kind in the country since 1984. Egypt has broken ground on a phosphoric acid complex in the New Valley, and in Tunisia, developer PhosCo is reporting high-grade discoveries near Kasserine.
For First Phosphate, the combination of the EIFO guarantee and the analyst response to it signals that the financing questions around the Quebec project are beginning to take shape. The governance vote, for its part, suggests that the existing shareholder base — however rapidly it is growing — remains comfortable with the direction of travel. Whether the growth story ultimately translates into a viable production business for battery-grade phosphate is a larger question that no annual meeting can answer. But with 12,501 holders now on the register, there are plenty of people waiting to find out.
Ad
First Phosphate Stock: Buy or Sell?! New First Phosphate Analysis from September 2 delivers the answer:
The latest First Phosphate figures speak for themselves: Urgent action needed for First Phosphate investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 2.
First Phosphate: Buy or sell? Read more here...
